Concepedia
Statistics
Publications
12
Citations
900
H-Index
11
Active since
1991
Affiliations
University of Wisconsin–Madison(Current)
University of Wisconsin Carbone Cancer Center
University of Wisconsin System
R Z Arzoomanian is an author at University of Wisconsin–Madison specializing in pharmacology, medicine, and oncology.
Publications per year
1991–2004
Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.
Howard H. Bailey, Ríona Mulcahy, K D Tutsch et al. · Journal of Clinical Oncology · 1994 · 186 citations
Medicine, Oncology, Pharmacology +11
Phase I Study of Continuous-Infusion L-S,R-Buthionine Sulfoximine With Intravenous Melphalan
Howard H. Bailey, Gregory H. Ripple, K D Tutsch et al. · JNCI Journal of the National Cancer Institute · 1997 · 165 citations · Full text
Medicine, Oncology, Pharmacology +15
Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer.
Joan H. Schiller, B. Storer, K D Tutsch et al. · Journal of Clinical Oncology · 1994 · 136 citations
Medicine, Oncology, Pharmacology +14
Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly.
Joan H. Schiller, Barry E. Storer, Patricia L. Witt et al. · PubMed · 1991 · 115 citations
Medicine, Oncology, Pharmacology +10
Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.
H. Ian Robins, Daniel A. Rushing, M Kutz et al. · Journal of Clinical Oncology · 1997 · 99 citations
Medicine, Oncology, Pharmacology +13
1–5 of 12